Arrowhead Pharmaceuticals Inc (ARWR)
Cash ratio
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 88,706 | 129,793 | 185,709 | 53,889 | 102,685 | 69,399 | 127,704 | 58,215 | 110,891 | 105,334 | 134,959 | 202,249 | 108,005 | 139,439 | 86,408 | 91,587 | 184,434 | 325,981 | 372,377 | 139,921 |
| Short-term investments | US$ in thousands | 830,660 | 770,579 | 911,700 | 499,046 | 578,276 | 367,272 | 395,410 | 162,064 | 292,735 | 346,369 | 346,046 | 299,582 | 268,391 | 277,057 | 315,487 | 238,547 | 183,355 | 190,331 | 204,941 | 165,406 |
| Total current liabilities | US$ in thousands | 195,487 | 194,530 | 220,541 | 93,758 | 103,168 | 96,714 | 65,175 | 63,723 | 105,456 | 70,227 | 87,151 | 66,281 | 74,099 | 128,212 | 138,857 | 137,032 | 146,536 | 195,434 | 167,188 | 25,094 |
| Cash ratio | 4.70 | 4.63 | 4.98 | 5.90 | 6.60 | 4.52 | 8.03 | 3.46 | 3.83 | 6.43 | 5.52 | 7.57 | 5.08 | 3.25 | 2.89 | 2.41 | 2.51 | 2.64 | 3.45 | 12.17 |
September 30, 2025 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($88,706K
+ $830,660K)
÷ $195,487K
= 4.70